Status:
RECRUITING
" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
Lead Sponsor:
South Valley University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-60 years
Brief Summary
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by diverse clinical manifestations, prominently involving the skin.
Detailed Description
Cutaneous lesions are among the earliest and most frequent features of SLE, with over 70% of patients developing mucocutaneous involvement during their disease course. The presence and severity of cu...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
June 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07397728
Start Date
June 10 2025
End Date
June 10 2026
Last Update
February 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qina University hospital, South Valley University Hospital
Qina, South Valley, Egypt